Sirtratumab vedotin (ASG15-ME) is an ADC composed of a SLITRK6-specific human gamma 2 antibody (Iggamma2) conjugated to a small molecule microtubule disrupting agent, monomethyl auristatin E (MMAE) via a protease-cleavable linker[1].
Purity:
96.42
CAS Number:
[1824663-83-3]
Target:
Antibody-Drug Conjugates (ADCs)
Application Notes:
ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted